BIOVIC B — Biovica International AB Share News
0.000.00%
Last trade - 00:00- SEK88.74m
- SEK43.18m
- SEK13.38m
Brief: Biovica Q2 Operating Loss SEK 25.3 Million
Brief: Biovica Gets Final Pricing Decision For Divitum TKa Test By Medicare
Brief: Biovica Signs Commercial Partner For DiviTum TKa Assay
Brief: Biovica Resolves On Partially Guaranteed Rights Issue Of SEK 120 Mln
Brief: Biovica Receives CAP Accreditation For Its CLIA Laboratory
Brief: Biovica Says DiviTum TKa To Pursue Gap-Fill Process For CMS Pricing Decision
Brief: Biovica Signs Second Agreement With U.S. Healthcare Provider
Brief: Biovica Signs Agreement With Healthcare Provider In Arizona
Brief: Biovica International Q1 Net Sales Up At SEK 1.8 Mln
Brief: Biovica Signs Commercial Agreement With Occum Health In US
Brief: Biovica Q4 Operating Loss Widens To SEK 37.2 Mln
Brief: Biovica Signs Provider Contract With Contigo Health ConfigureNet
Brief: Biovica Establishes Commercialization Partnership In Italy
Brief: Biovica Signs Commercial Partner Agreement For Dutch, Polish Markets
Brief: Biovica International Q3 Operating Loss Widens To SEK 29.3 Mln
Brief: Biovica Receives CLIA Certification
Brief: Biovica's Divitum Clinical Validation Data In Biomarkers
Brief: Biovica Q2 Oper Loss Widens To SEK 23.3 Mln
Brief: Biovica International Announces Outcome Of Rights Issue